SHAMEKA JOHNSON: Open Payments
NPI 1972215382 · SMITHFIELD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,341 in 147 payments from 13 companies in 2025. Trend: 2023 $1,608 · 2024 $3,168 · 2025 $3,341
Food & beverage: $3,341
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 23 | $749 |
| E.R. Squibb & Sons, L.L.C. | 18 | $549 |
| Otsuka America Pharmaceutical, Inc. | 23 | $466 |
| ABBVIE INC. | 23 | $373 |
| Vanda Pharmaceuticals Inc. | 14 | $327 |
| Teva Pharmaceuticals USA, Inc. | 19 | $296 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $182 |
| Janssen Pharmaceuticals, Inc | 7 | $176 |
| Neurocrine BioSciences, Inc. | 8 | $135 |
| Lundbeck LLC | 1 | $27 |
Products named: COBENFY, ARISTADA, VRAYLAR, REXULTI, HETLIOZ, LYBALVI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
